Correction of doxorubicin-induced hepatotoxicity by glucosamine derivatives and their combinations with quercetin in rats
DOI:
https://doi.org/10.24959/cphj.14.1306Keywords:
doxorubicin, hepatotoxicity, glucosamine derivatives, quercetinAbstract
The article presents the results of the pharmacological study of glucosamine derivatives and their combinations with flavonoid quercetin as correctors of hepatotoxicity of anthracycline antibiotics, particularly doxorubicin. As the test compounds substances of glucosamine hydrochloride in conventionally therapeutic doses of 50 mg/kg, and the combination of aminosugars of glucosamine hydrochloride and N-acetylglucosamine with flavonoid quercetin in the ratio of 3:1 equivalent to glucosamine hydrochloride in a conventionally therapeutic dose of 82 mg/kg have been studied. Quercetin was used in the dose of 20.5 mg/kg as a reference medicine. To assess the degree of liver damage and severity of the hepatoprotective activity of the objects selected a number of biochemical parameters (the level of TBA-reactants of the serum and the liver homogenate, the activity of indicator enzymes of ALT, AST cytolysis, the content of the total protein, glucose, urea in the serum) have been determined; the the histomorphologic study of liver tissue has been conducted. According to the experimental results it has been found that all tested compounds have the ability to reduce the toxic effects of doxorubicin in relation to the liver. With respect to overall rating of the parameters studied a combination of aminosugars of glucosamine hydrochloride and N-acetylglucosamine with quercetin has shown the most significant hepatoprotective effect, and it can be explained by a synergistic action of its individual components directed to inhibition of free radical processes and cytolysis, inhibition of inflammation, urea formation function, protein synthesis in the liver, normalization of the carbohydrate metabolism and decrease of hypoplastic changes in the liver tissue. The results of the study experimentally substantiate the use perspectiveness of a combination of aminosugars of glucosamine hydrochloride and N-acetylglucosamine with quercetin for pharmacological correction of toxic effects of anthracycline antibiotics during anticancer therapy.
References
Бессергенева Е.П., Жукова Н.А., Толстикова Т.Г., Сорокина И.В. // Сибирский онкол. журн. – 2011. – №6. – С. 41-46.
Гордієнко Ю.А., Бакланова Я., Коваленко М.В. та ін. // Біологія тварин. – 2012. – Т. 14, №1/2. – http://aminbiol.com.ua/2012pdf/8.pdf
Ермолаева Л.А. Гепатотоксичность противоопухолевых препаратов растительного происхождения паклитаксела и этопозида и ее фармакологическая коррекция: Автореф. дис. … канд. мед. наук: 14.00.25, 14.00.14; ГУ НИИ фармакологии Томского научного центра СО РАМН. – Томск, 2008. – 22 с.
Зупанец И.А. Экспериментальное обоснование использования глюкозамина и его производных в медицине: Дис. ... д-ра мед. наук (в форме научного доклада). – Купавна, 1993. – 90 с.
Зупанець К.О., Отрішко І.А. // Вісник фармації. – 2010. – №1. – С. 69-71.
Казюлин А.Н., Вельшер Л.З., Данилевская Н.Н., Маевская Е.А. // Фарматека. – 2012. – №8. – С. 37-44.
Ким Т.В., Грек О.Р., Толстикова Т.Г. и др. // Вестник новых мед. технол. – 2010. – Т. 17, №1. – С. 174-175.
Кляритская И.Л., Максимова Е.В. // Новости медицины и фармации. – 2010. – №11/12. – http:// www.mif-ua.com/archive/article/12893
Кубишкін А.В., Мальченко О.А., Мандрик Ю.В. // Експеримент. та клінічна фізіол. і біохімія. – 2013. – №4. – С. 12-19.
Меркулов Г.А. Курс патологогистологической техники. – М.: Медицина, Ленингр. отд-ние, 1969. – 424 с.
Микуляк Н.И., Митрошин А.Н., Микуляк А.И. // Вестник новых мед. технол. – 2008. – Т. XV, №4. – С. 30-33.
Молодых О.П., Лушникова Е.Л., Клинникова М.Г., Непомнящих Л.М. // Бюл. эксперимент. биол. и медицины. – 2006. – Т. 141, №5. – С. 579-585.
Пат. Российской Федерации №2285532 «Способ коррекции токсических поражений, вызванных доксорубицином» МПК А 61 К 31/704; А 61 К 31/4196; А 61 Р 35/00 / И.С.Чекман, Н.А.Горчакова, Т.С.Трофимова и др.; заявитель и патентообладатель ООО «НПО «Фарматрон» (UA); НМУ им.
А.А.Богомольца (UA). – №2004131489/14. Заявл.: 28.10.2004. Опубл.: 20.10.2006. – 5 с.
Полунина Т.Е., Маев И.В. // Мед. совет. – 2010. – №11/12. – С. 83-84.
Пятница-Горпинченко Н. // Здоров’я України. – 2011. – №18. – С. 74.
Туляков В.О., Зупанець К.О., Шебеко С.К. // Фармакол. та лікарська токсикол. – 2009. – №3. – С. 3-9.
Туляков В.О., Зупанець К.О., Шебеко С.К. // Фармакол. та лікарська токсикол. – 2009. – №2. – С. 3-8.
Чернадчук С.С., Федорко Н.Л., Захариева З.Е. и др. Методические указания для выполнения экспериментальных исследований по большому специальному практикуму «Методы оценки состояния оксидантной и антиоксидантной систем биологических объектов». – Одесса, 2010. – 52 с.
Яковлєва Л.В., Силаєв А.О., Лар’яновська Ю.Б. та ін. // Клінічна фармація. – 2011. – Т. 15, №2. – С. 47-51.
Mohan M., Kamble S., Satyanarayana J. et al. // Intern. J. of Drug Development & Res. – 2011. – №3. – P. 131-138.
Park H.K., Kim S.J., Kwon D.Y. et al. // Life Sci. – 2010. – Vol. 87, №5/6. – P. 181-186.
Pavanato A., Tunon M.J., Sanchez-Campos S. et al. // Digestive Dis. and Sci. – 2003. – Vol. 48, №4. – P. 824-829.
Pieniążek A., Czepas J., Piasecka-Zelga J. et al. // Advances in Medical Sci. – 2013. – Vol. 58, Issue 1. – P. 104-111.
Yang Yan, Liu Wanshun, Han Baoqin et al. // Hepatol. Res. – 2006. – Vol. 35, Issue 3. – P. 178-184.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).